sb 203580 has been researched along with suramin in 5 studies
| Studies (sb 203580) | Trials (sb 203580) | Recent Studies (post-2010) (sb 203580) | Studies (suramin) | Trials (suramin) | Recent Studies (post-2010) (suramin) |
|---|---|---|---|---|---|
| 3,489 | 4 | 1,137 | 3,023 | 92 | 431 |
| Protein | Taxonomy | sb 203580 (IC50) | suramin (IC50) |
|---|---|---|---|
| ATP-dependent 6-phosphofructokinase | Trypanosoma brucei brucei | 3 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 9.76 | |
| P2X purinoceptor 2 | Rattus norvegicus (Norway rat) | 4 | |
| DNA-dependent protein kinase catalytic subunit | Homo sapiens (human) | 1.7 | |
| DNA primase | Mycobacterium tuberculosis CDC1551 | 8.2 | |
| RmtA | Aspergillus nidulans | 5.9 | |
| Reverse transcriptase/RNaseH | Human immunodeficiency virus 1 | 9.4 | |
| NAD-dependent protein deacetylase sirtuin-2 | Homo sapiens (human) | 1.15 | |
| NAD-dependent protein deacetylase sirtuin-1 | Homo sapiens (human) | 1.5667 | |
| Protein arginine N-methyltransferase 1 | Homo sapiens (human) | 5.33 | |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | Homo sapiens (human) | 2.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| McGovern, SL; Shoichet, BK | 1 |
| Jaakkola, P; Jalkanen, M; Kauppi, T; Kontusaari, S; Määtä, A | 1 |
| Huwiler, A; Pfeilschifter, J; van den Bosch, H; Wartmann, M | 1 |
| Kandolf, R; Küpper, JH; Meyer, RG; Rodemann, HP | 1 |
| Fang, W; He, C; Heng, W; Li, H; Wu, B; You, J; Zheng, J | 1 |
5 other study(ies) available for sb 203580 and suramin
| Article | Year |
|---|---|
Kinase inhibitors: not just for kinases anymore.
Topics: beta-Lactamase Inhibitors; beta-Lactamases; Chymotrypsin; Enzyme Inhibitors; Kinetics; Light; Malate Dehydrogenase; Models, Biological; Phosphotransferases; Scattering, Radiation | 2003 |
Wound reepithelialization activates a growth factor-responsive enhancer in migrating keratinocytes.
Topics: Animals; Anisomycin; Calcium-Calmodulin-Dependent Protein Kinases; Cell Division; Cell Line; Cell Movement; Enhancer Elements, Genetic; Enzyme Inhibitors; Epithelium; Fibroblast Growth Factors; Flavonoids; Gene Expression Regulation; Genistein; Imidazoles; In Vitro Techniques; Keratinocytes; Membrane Glycoproteins; Mice; Mice, Transgenic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Proteoglycans; Pyridines; Receptors, Growth Factor; Skin Physiological Phenomena; Suramin; Syndecan-1; Syndecans; Transcriptional Activation; Wound Healing | 1998 |
Extracellular nucleotides activate the p38-stress-activated protein kinase cascade in glomerular mesangial cells.
Topics: Activating Transcription Factor 2; Adenosine Triphosphate; Animals; Blotting, Western; Calcium-Calmodulin-Dependent Protein Kinases; Cattle; Cyclic AMP Response Element-Binding Protein; Enzyme Activation; Enzyme Inhibitors; Glomerular Mesangium; GTP-Binding Proteins; Imidazoles; Isoenzymes; Mitogen-Activated Protein Kinases; Nucleotides; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Pyridines; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2Y2; Stress, Physiological; Suramin; Transcription Factors; Uridine Triphosphate | 2000 |
Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitro.
Topics: Androstadienes; Anisomycin; Blotting, Western; Colforsin; DNA-Binding Proteins; Early Growth Response Protein 1; Epidermal Growth Factor; Flavonoids; Glioma; Humans; Imidazoles; Immediate-Early Proteins; Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Promoter Regions, Genetic; Pyridines; Suramin; Transcription Factors; Wortmannin | 2002 |
[Activation of p38 and c-Jun NH2-terminal kinase mitogen-activated protein kinases in human prostate carcinoma cell lines with different metastatic potentials].
Topics: Adenosine Triphosphate; Cell Line, Tumor; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Male; Neoplasm Metastasis; p38 Mitogen-Activated Protein Kinases; Prostatic Neoplasms; Purinergic P2 Receptor Agonists; Pyridines; Signal Transduction; Suramin | 2001 |